Prognosis in Thai colorectal-cancer patients with GSTM1 and GSTT1 copy number variation
Keywords:
glutathione S-transferase M1, glutathione S-transferase T1, DNA copy number variation, colorectal cancerAbstract
Background: Glutathione S-transferase (GST) enzymes including GSTM1 and GSTT1 are involved in the detoxification of carcinogenic compounds. Null genotypes of GSTM1 and GSTT1 may result in reduced enzyme activity and be associated with susceptibility to various cancers. The detection of DNA copy number variation (CNV) by real-time PCR is reportedly very effective for detecting GSTM1 and GSTT1. This study investigated the association between GSTM1 and GSTT1 copy number variations and clinico-pathological parameters and gene copy number variation, and their potential relationship with the survival status of colorectal-cancer patients. Methods: Fifty-three Thai colorectal-cancer patients were investigated for GSTM1 and GSTT1 copy number variation by real-time PCR. Correlations between gene copy number variation and clinico-pathological characteristics were analyzed. Results: The results showed an association between GSTM1 copy number variation with stage and lymph-node metastasis. Increases in GSTM1 copy number were related to a negative prognosis and reduced survival status of patients. No association was found between GSTT1 copy number variation with patients’ clinico-pathological parameters and survival. Conclusions: The results demonstrated that GSTM1 copy number variation may be used in guiding the prognosis for Thai colorectal-cancer patients.Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.